Are cruise operators paying attention to food trends?
How low can you go? Ultra-light beer redefines the light concept
Light beer is getting lighter. Though sales of top-selling light beer brands like Bud Light, Coors Light, and Miller Light have been eroding for nearly a decade in the US, the success of AB InBev’s Michelob Ultra product has given the industry hope. Tom Vierhile examines the new wave of innovators seeking to establish a new ultra-light premium beer niche.
Should airports have their own microgrids?
After Atlanta Hartsfield-Jackson International Airport experienced a major power supply disruption, the Rocky Mountain Institute was awarded a $450,000 research grant to develop a microgrid implementation toolkit to help airports avoid disaster. Elliot Gardner finds out more from RMI’s director of sustainable aviation Adam Klauber.
Lost in transmission: why upgrading the UK’s network should be top of the agenda
While the UK Government churns out strategies to meet its ambitions of leading the world on decarbonisation, it is failing to tackle a fundamental issue in the country’s energy network. Dominic Quennell, managing director of Enertechnos Energy, explains why energy losses shouldn’t be ignored.
A storm is brewing for India’s domestic shipping industry
India’s domestic shipping industry is considering its options after the central government relaxed cabotage rules. It now looks set to do away with a ‘right of first refusal’ that gives Indian shippers a chance to match the lowest rate offered by foreign ships. But what are the potential implications of this, Joe Baker asks?
Urgent concern: how mining damages wildlife on land and at sea
The work of mining companies can have a significant – and often destructive – impact on local wildlife. Guidelines and legislation operating above the level of national governments could help to guide mining towards a less destructive future, but questions remain, as JP Casey finds out.
Selling cells: the economics of CAR-T therapy
As a new class of CAR-T cell therapies moves through clinical trials and the first of these innovative treatments enters the market, the therapy is causing almost as much consternation as excitement in the healthcare sphere. While CAR-T looks set to transform the treatment of cancer, what does the future hold for one of the industry’s most advanced – and expensive – treatments? Sally Turner finds out.